WHO expects to get results within next two weeks from clinical trials it is conducting of drugs that might be effective in treating Covid-19 patients – Director General
Blood samples from patients infected with the coronavirus disease are prepared for analysis as part of the TACTIC-R trial, in the Blood Processing Lab in the Cambridge Institute of Therapeutic Immunology and Infectious Disease, in Cambridge, Britain May 21, 2020.
The Solidarity Trial started out in five parts looking at possible treatment approaches to Covid-19: standard care; remdesivir; the anti-malaria drug touted by US President Donald Trump, hydroxychloroquine; the HIV drugs lopinavir/ritonavir; and lopanivir/ritonavir combined with interferon. There is no proven vaccine against the disease now, while 18 potential candidates are being tested on humans.
"I regret that there wasn't fair, accessible access to Covid tools. I regret that some countries had more than others, and I regret that front-line workers died because of ," he said. WHO has updated its account of the early stages of the Covid-19 crisis to say it was alerted by its own office in China, and not by China itself, to the first pneumonia cases in Wuhan.
In that chronology, WHO had said only that the Wuhan municipal health commission in the province of Hubei had on December 31 reported cases of pneumonia. The UN health agency did not, however, specify who had notified it.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mike Trout unsure he'll play in 2020 because he's 'very concerned' about COVID-19Mike Trout
Read more »
COVID-19 vaccines to enter late-stage trial by end of July, Fauci saysCOVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and October, the U.S. government's top infectious diseases expert said on Thursday.
Read more »
'Right thing' to be part of Covid-19 plasma trialThe first person to get blood plasma as a coronavirus treatment explains why she's taking part in the trial.
Read more »
Experts Worry Latest Covid-19 Surge Will Shift From Healthier to At-Risk PeopleThe predominance of younger, healthier patients where Covid-19 is surging in the U.S. could mean better outcomes, health authorities say, but they are concerned the coronavirus may yet spread to older and more-vulnerable populations.
Read more »